Carol A. Tamminga

Prof. Carol A. Tamminga


Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2010 in American Journal of Psychiatry
Verified
Journal Article
Closed access
CTCarol A. Tamminga
Carol A. Tamminga
ASAna D. Stan
Ana D. Stan
AWAnthony D. Wagner
Anthony D. Wagner

1 November 2013 in American Journal of Psychiatry
Verified
Journal Article
Closed access
PDF file
CTCarol A. Tamminga
Carol A. Tamminga
EIElena I. Ivleva
Elena I. Ivleva
MKMatcheri S. Keshavan
Matcheri S. Keshavan
GPGodfrey D. Pearlson
Godfrey D. Pearlson
BCBrett A. Clementz
Brett A. Clementz
JSJohn A. Sweeney
John A. Sweeney

1 December 2006 in Brain Research
Verified
Journal Article
Closed access
ASAna D. Stan
Ana D. Stan
SGSubroto Ghose
Subroto Ghose
XGXue-Min Gao
Xue-Min Gao
RRRosalinda C. Roberts
Rosalinda C. Roberts
KLKelly Lewis-Amezcua
Kelly Lewis-Amezcua
CTCarol A. Tamminga
Carol A. Tamminga

20 February 2014 in Schizophrenia Bulletin
Verified
Journal Article
Open access
PDF file
CTCarol A. Tamminga
Carol A. Tamminga
GPGodfrey Pearlson
Godfrey Pearlson
MKMatcheri Keshavan
Matcheri Keshavan
JSJohn Sweeney
John Sweeney
BCBrett Clementz
Brett Clementz
GTGunvant Thaker
Gunvant Thaker
Bipolar and schizophrenia network for intermediate phenotypes is a network of investigator-driven laboratories focused on developing phenotypes, genotypes, and biomarkers for psychosis. Over the last 5 years, the consortium has accomplished a dense phenotyping protocol using probands with a lifetime history of psychosis, their relatives, and healthy controls. This has established a library of biomarker information on individuals with schizophrenia, schizoaffective disorder, and bipolar disorder with psychosis. The founding goal of establishing disease biomarkers for current psychotic diagnoses has been poorly met, because the cognitive, electrophysiologic, eye movement, and brain imaging biomarkers did not regularly discriminate individuals with different DSM psychosis diagnoses. In future, we will use this biomarker information to establish a pathway to biomarker-based classification in psychoses.

31 August 2004 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
CTCarol A. Tamminga
Carol A. Tamminga
HHH H Holcomb
H H Holcomb

24 April 2012 in Schizophrenia Bulletin
Verified
Journal Article
Open access
PDF file
CTCarol A. Tamminga
Carol A. Tamminga
SSSarah Southcott
Sarah Southcott
CSCarolyn Sacco
Carolyn Sacco
AWAnthony D. Wagner
Anthony D. Wagner
SGSubroto Ghose
Subroto Ghose
Synaptic glutamate signaling in brain is highly complex and includes multiple interacting receptors, modulating cotransmitters and distinct regional dynamics. Medial temporal lobe (MTL) memory structures receive excitatory inputs from neocortical sensory and associational projections: afferents from neocortex pass to parahippocampal cortex, then to layers II/III of entorhinal cortex, and then onto hippocampal subfields. Principles of Hebbian plasticity govern synaptic encoding of memory signals, and homeostatic plasticity processes influence the activity of the memory system as a whole. Hippocampal imaging studies in schizophrenia have identified 2 alterations in MTL—increases in baseline blood perfusion and decreases in task-related activation. These observations along with converging postsynaptic hippocampal protein changes suggest that homeostatic plasticity mechanisms might be altered in schizophrenia hippocampus. If hippocampal pattern separation is diminished due to partial dentate gyrus failure (resulting in ‘spurious associations’) and also if pattern completion is accelerated and increasingly inaccurate due to increased CA3 associational activity, then it is conceivable that associations could be false and, especially if driven by anxiety or stress, could generate psychotic content, with the mistaken associations being laid down in memory, despite their psychotic content, especially delusions and thought disorder.